In our study, vaccine breakthrough infection was linked to a more rapid, earlier peaking and more extensive expansion of Spike-specific T cells and, similarly, to dramatically higher antibody levels against the vaccine-encoded S-protein compared to non-BTI. The gene discussed is PROS1; the disease is infection.